Thiazolyl-essigsaeure

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑啉类
• 英文名称: Thiazolyl-essigsaeure
• 英文别名: (5,6-dihydro-imidazo[2,1-b]thiazol-3-yl)-acetic acid；2-(6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazol-4-ium-3-yl)acetate
• 化学式: C₇H₈N₂O₂S
• mdl: MFCD06009688
• 分子量: 184.219
• InChiKey: KYLGVTXSFSDBGX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.428
• 拓扑面积：
  78.2
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  、 Thiazolyl-essigsaeure 在 1-羟基苯并三唑 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 16.0h， 生成
  参考文献：
  名称：

  Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain

  摘要：

  Rhodesain, the major cathepsin L-like cysteine protease in the protozoan Trypanosoma brucei rhodesiense, the causative agent of African sleeping sickness, is a well-validated drug target. In this work, we used a fragment-based approach to identify inhibitors of this cysteine protease, and identified inhibitors of T. brucei. To discover inhibitors active against rhodesain and T. brucei, we screened a library of covalent fragments against rhodesain and conducted preliminary SAR studies. We envision that in vitro enzymatic assays will further expand the use of the covalent tethering method, a simple fragment-based drug discovery technique to discover covalent drug leads. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2015.08.074
• 作为产物：
  描述：

  (5,6-dihydro-imidazo[2,1-b]thiazol-3-yl)-acetic acid ethyl ester 在 甲烷磺酸 作用下， 生成 Thiazolyl-essigsaeure
  参考文献：
  名称：

  来自咪唑啉-2-硫醇衍生物，不饱和或卤代酸和酯的2,3,5,6-四氢-和5,6-二氢-咪唑并[ 2,1- b ]噻唑

  摘要：

  证据表明，咪唑啉-2-硫醇与乙炔二羧酸及其二甲基酯的反应产物是5，6-二氢咪唑并[ 2，1- b ]噻唑-3（2 H）-one的衍生物。该咪唑啉-2-硫醇与马来酸酐，α-溴-二羧酸及其二乙酯的反应可制得该环系的其他衍生物。用2-咪唑啉-2-巯基的2-氯乙酰乙酸乙酯和4-溴乙酰乙酸乙酯得到5,6-二氢咪唑并[2,1- b ]噻唑的衍生物，并保留了乙氧基羰基。5-取代的2-硫代乙内酰脲以相似的方式反应。

  DOI：

  10.1039/j39710003602

文献信息

• CAMPAIGNE E.; SELBY T. P., J. HETEROCYCL. CHEM., 1980, 17, NO 6, 1255-1257
  作者：CAMPAIGNE E.、 SELBY T. P.

  DOI：——

  日期：——
• Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain
  作者：Danielle McShan、Stefan Kathman、Brittiney Lowe、Ziyang Xu、Jennifer Zhan、Alexander Statsyuk、Ifedayo Victor Ogungbe

  DOI：10.1016/j.bmcl.2015.08.074

  日期：2015.10

  Rhodesain, the major cathepsin L-like cysteine protease in the protozoan Trypanosoma brucei rhodesiense, the causative agent of African sleeping sickness, is a well-validated drug target. In this work, we used a fragment-based approach to identify inhibitors of this cysteine protease, and identified inhibitors of T. brucei. To discover inhibitors active against rhodesain and T. brucei, we screened a library of covalent fragments against rhodesain and conducted preliminary SAR studies. We envision that in vitro enzymatic assays will further expand the use of the covalent tethering method, a simple fragment-based drug discovery technique to discover covalent drug leads. (C) 2015 Elsevier Ltd. All rights reserved.
• 2,3,5,6-Tetrahydro- and 5,6-dihydro-imidazo[2,1-b]thiazoles from imidazoline-2-thiol derivatives and unsaturated or halogenated acids and esters
  作者：R. B. Blackshire、C. J. Sharpe

  DOI：10.1039/j39710003602

  日期：——

  imidazoline-2-thiol with maleic anhydride and with α-bromo-dicarboxylic acids and their diethyl esters. Ethyl 2-chloro- and 4-bromoacetoacetate with imidazoline-2-thiol give derivatives of 5,6-dihydroimidazo[2,1-b]thiazole with retention of the ethoxycarbonyl group. 5-Substituted 2-thiohydantoins react in a similar way.

  证据表明，咪唑啉-2-硫醇与乙炔二羧酸及其二甲基酯的反应产物是5，6-二氢咪唑并[ 2，1- b ]噻唑-3（2 H）-one的衍生物。该咪唑啉-2-硫醇与马来酸酐，α-溴-二羧酸及其二乙酯的反应可制得该环系的其他衍生物。用2-咪唑啉-2-巯基的2-氯乙酰乙酸乙酯和4-溴乙酰乙酸乙酯得到5,6-二氢咪唑并[2,1- b ]噻唑的衍生物，并保留了乙氧基羰基。5-取代的2-硫代乙内酰脲以相似的方式反应。